Literature DB >> 2894217

The comparative effects of ICI 118551 and propranolol on essential tremor.

D Jefferson1, H J Wharrad, A T Birmingham, J M Patrick.   

Abstract

1. The effects of the selective beta 2-adrenoceptor antagonist ICI 118551 on essential tremor, heart rate and blood pressure were compared with those of propranolol. 2. ICI 118551 (150 mg daily for 7 days) and propranolol (120 mg daily for 7 days) were about equally effective in reducing essential tremor (by about 40%) and were more effective than placebo. 3. When compared with the effect of placebo, propranolol reduced blood pressure and exercise heart rate whereas ICI 118551 had no significant effect on blood pressure and produced a small but significant reduction in exercise-induced tachycardia. 4. ICI 118551 may be useful in the management of essential tremor while having fewer cardiovascular side-effects than non-selective beta-adrenoceptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2894217      PMCID: PMC1386396          DOI: 10.1111/j.1365-2125.1987.tb03238.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties.

Authors:  G F Winkler; R R Young
Journal:  N Engl J Med       Date:  1974-05-02       Impact factor: 91.245

2.  Propranolol in the treatment of tremor.

Authors:  B S Gilligan; J L Veale; J Wodak
Journal:  Med J Aust       Date:  1972-02-12       Impact factor: 7.738

3.  Evidence that ICI 118, 551 is a potent, highly Beta 2-selective adrenoceptor antagonist and can be used to characterize Beta-adrenoceptor populations in tissues.

Authors:  S R O'Donnell; J C Wanstall
Journal:  Life Sci       Date:  1980-08-25       Impact factor: 5.037

4.  The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man.

Authors:  S B Pearson; D C Banks; J M Patrick
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

5.  Peripheral beta-adrenergic receptors concerned with tremor.

Authors:  C D Marsden; T H Foley; D A Owen; R G McAllister
Journal:  Clin Sci       Date:  1967-08       Impact factor: 6.124

6.  The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment.

Authors:  B Abila; J F Wilson; R W Marshall; A Richens
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

7.  Effect of beta-adrenergic blockade on respiratory and metabolic responses to exercise.

Authors:  O P Twentyman; A Disley; H R Gribbin; K G Alberti; A E Tattersfield
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-10

8.  Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor.

Authors:  S Calzetti; L J Findley; E Perucca; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

9.  Metoprolol and propranolol in essential tremor: a double-blind, controlled study.

Authors:  S Calzetti; L J Findley; M A Gresty; E Perucca; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-09       Impact factor: 10.154

10.  Effects of timolol and atenolol on benign essential tremor: placebo-controlled studies based on quantitative tremor recording.

Authors:  P Dietrichson; E Espen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-08       Impact factor: 10.154

View more
  5 in total

Review 1.  Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man.

Authors:  P Turner
Journal:  Postgrad Med J       Date:  1989-01       Impact factor: 2.401

2.  Cardiac beta 2-adrenoceptors and the inotropic response to exercise in man.

Authors:  C Nyarko-Adomfeh
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

Review 3.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849

4.  Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling.

Authors:  Alexander Samoshkin; Marino Convertino; Chi T Viet; Jeffrey S Wieskopf; Oleg Kambur; Jaclyn Marcovitz; Pinkal Patel; Laura S Stone; Eija Kalso; Jeffrey S Mogil; Brian L Schmidt; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Sci Rep       Date:  2015-12-11       Impact factor: 4.379

Review 5.  Essential Tremor: What We Can Learn from Current Pharmacotherapy.

Authors:  William Ondo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.